Purchases and Sales Made in Q4 2023 in Monopar Therapeutics (MNPR)
This table provides information about the institutional ownership of Monopar Therapeutics (MNPR) during Q4 2023. The information is specifically focused on institutions that hold shares of Monopar Therapeutics.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
48.1KNew |
$13.9K - $28.9K
|
48.1K
$2.33M
|
|
|
Mar 05, 2024
Q4 2023
|
Gerber, LLC
Columbus, OH |
BUY
|
- |
28KNew |
$8.12K - $16.8K
|
28K
$1.36M
|
|
|
Feb 26, 2024
Q4 2023
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
27.2KNew |
$7.88K - $16.3K
|
27.2K
$1.32M
|
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
14.3KNew |
$4.15K - $8.58K
|
14.3K
$694K
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
BUY
|
- |
11.8K+ 16426.39% |
$3.43K - $7.1K
|
11.9K
$577K
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
800New |
$232 - $480
|
800
$38.8K
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
532+ 5.09% |
$154 - $319
|
11K
$533K
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
4+ 12.12% |
$1.16 - $2.4
|
37
$1.79K
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-109- 2.92% |
$31.6 - $65.4
|
3.62K
$175K
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-3.42K- 10.44% |
$992 - $2.05K
|
29.3K
$1.42M
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-42.4K- 48.44% |
$12.3K - $25.5K
|
45.2K
$2.19M
|